Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1677
    +0.0021 (+0.18%)
     
  • GBP/USD

    1.2502
    -0.0009 (-0.07%)
     
  • Bitcoin GBP

    51,178.87
    -497.39 (-0.96%)
     
  • CMC Crypto 200

    1,333.55
    -62.99 (-4.51%)
     
  • S&P 500

    5,110.58
    +62.16 (+1.23%)
     
  • DOW

    38,297.75
    +211.95 (+0.56%)
     
  • CRUDE OIL

    83.76
    +0.19 (+0.23%)
     
  • GOLD FUTURES

    2,352.40
    +9.90 (+0.42%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Can The Uptrend Continue for Infinity Pharmaceuticals (INFI)?

Wall Street finished in the green reversing its five-day negative trend on Thursday following news that United States and China have ramped up their efforts to resolve lingering trade disputes

Investors certainly have to be happy with Infinity Pharmaceuticals, Inc. INFI and its short term performance. After all, the stock has jumped by 35.7% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well. This is certainly a good trend, but investors are probably asking themselves, can this positive trend continue for INFI?

While we can never know for sure, it is pretty encouraging that estimates for INFI have moved higher in the past few weeks, meaning that analyst sentiment is moving in the right way. Plus, the stock actually has a Zacks Rank #1 (Strong Buy), so the recent move higher for this spotlighted company may definitely continue over the next few weeks.

Zacks Editor-in-Chief Goes ""All In"" on This Stock

Full disclosure, Kevin Matras now has more of his own money in one particular stock than in any other. He believes in its short-term profit potential and also in its prospects to more than double by 2019. Today he reveals and explains his surprising move in a new Special Report.

ADVERTISEMENT

Download it free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Infinity Pharmaceuticals, Inc. (INFI) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research